Australia amends Copyright Act for easier access to generic drugs
This article was originally published in SRA
Executive Summary
The Australian Parliament has cleared legislation to ensure that brand-name pharmaceutical companies can no longer claim infringement of copyright on their product information documents to delay or prevent generic medicines from entering the market1,2.